Eli Lilly and Company is a global pharmaceutical leader headquartered in Indianapolis, Indiana, USA. Founded in 1876, the company has grown into one of the world's largest and most respected drug manufacturers, employing over 35,000 people worldwide. Its mission is to create medicines that make life better for people around the globe, with a focus on innovation, patient-centric care, and scientific excellence. Eli Lilly's portfolio spans therapeutic areas including diabetes, oncology, immunology, neuroscience, and pain management, with several flagship products such as insulin therapies and cancer treatments.
Renowned for its research-driven approach, Eli Lilly invests heavily in R&D and collaborates with academic institutions, biotech firms, and healthcare providers to advance medical science. In recent years, the company has gained significant attention for its groundbreaking work in obesity and diabetes treatments, including the development of tirzepatide, a promising drug for weight management and glycemic control. Eli Lilly's strong market position is reinforced by its robust pipeline, global reach, and commitment to addressing unmet medical needs, making it a key player in shaping the future of healthcare.